Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subsets in systemic lupus erythematosus.

T T Provost

    The Journal of Investigative Dermatology
    |March 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Systemic lupus erythematosus (SLE) comprises distinct patient subsets defined by specific autoantibodies. These subsets exhibit unique clinical features and varying risks of kidney disease, impacting patient prognosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Calciphylaxis in a patient without renal failure or elevated parathyroid hormone: possible aetiological role of chemotherapy.

    The British journal of dermatology·2000
    Same author

    Generalized lupus erythematosus profundus in a patient with genetic partial deficiency of C4.

    Journal of the American Academy of Dermatology·1999
    Same author

    Neurology and the skin.

    Journal of neurology, neurosurgery, and psychiatry·1999
    Same author

    "Centripetal flagellate erythema": a cutaneous manifestation associated with dermatomyositis.

    The Journal of rheumatology·1999
    Same author

    Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry.

    Journal of the American College of Cardiology·1998
    Same author

    Serum CA-125 screening for ovarian cancer in patients with dermatomyositis.

    Gynecologic oncology·1997
    Same journal

    Residual CSB activity explains mild UV-sensitive syndrome phenotype caused by CSB mutations.

    The Journal of investigative dermatology·2026
    Same journal

    Charting a new melanoma risk factor: Satellite Naevus Prevalence in High-Risk and Population-Based Cohorts.

    The Journal of investigative dermatology·2026
    Same journal

    Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris.

    The Journal of investigative dermatology·2026
    Same journal

    Merkel cells attenuate autoantigen-specific T cell driven skin inflammation in mice associated with reduced neutrophil recruitment.

    The Journal of investigative dermatology·2026
    Same journal

    The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.

    The Journal of investigative dermatology·2026
    Same journal

    Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled Trial.

    The Journal of investigative dermatology·2026
    See all related articles

    Area of Science:

    • Immunology
    • Rheumatology
    • Clinical Medicine

    Background:

    • Systemic lupus erythematosus (SLE) is a complex autoimmune disease.
    • Emerging evidence suggests heterogeneity within SLE patient populations.
    • Distinct clinical phenotypes and prognoses are increasingly recognized.

    Purpose of the Study:

    • To investigate the existence and characteristics of different systemic lupus erythematosus (SLE) subsets.
    • To determine if specific autoantibody profiles correlate with distinct clinical manifestations and disease outcomes.
    • To understand the implications of these subsets on patient prognosis, particularly regarding renal disease.

    Main Methods:

    • Analysis of patient data from multiple research laboratories.
    • Characterization of systemic lupus erythematosus (SLE) subsets based on autoantibody specificities.

    Related Experiment Videos

  • Correlation of autoantibody profiles with mucocutaneous features and renal disease prevalence.

    • Main Results:

    • Evidence supports the existence of various systemic lupus erythematosus (SLE) subsets.
    • Certain SLE subsets display characteristic mucocutaneous features.
    • Significant differences in renal disease prevalence and, consequently, prognosis exist among these subsets.

    Conclusions:

    • Systemic lupus erythematosus (SLE) is not a monolithic disease but comprises distinct subsets.
    • Autoantibody specificity is a key factor in defining these SLE subsets.
    • Identifying SLE subsets is crucial for predicting disease course and tailoring patient management, especially concerning kidney involvement.